Evidence map›Paper›PMID 26685208›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

The Transcription Factor ARID3a Is Important for In Vitro Differentiation of Human Hematopoietic Progenitors.

Michelle L Ratliff, Meenu Mishra, Mark B Frank, Joel M Guthridge, Carol F Webb

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. mBio · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. LIN28-FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michelle L RatliffOklahoma Medical Research Foundation, Oklahoma City, OK 73104;
Meenu MishraWalter Reed Army Institute of Research, Silver Spring, MD 20910;
Mark B FrankOklahoma Medical Research Foundation, Oklahoma City, OK 73104;
Joel M GuthridgeOklahoma Medical Research Foundation, Oklahoma City, OK 73104;
Carol F WebbOklahoma Medical Research Foundation, Oklahoma City, OK 73104; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104; and Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 carol-webb@ouhsc.edu.ORCID http://orcid.org/0000-0003-4164-9634
Oklahoma Medical Research Foundation · USWalter Reed Army Institute of Research · US

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Bright Function in the Immune SystemR01AI044215 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI WEBB, CAROL F · 1999 to 2009
$2.4M
Role of the transcription factor ARID3a in innate immune responsesR01AI118836 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WEBB, CAROL F · 2017 to 2020
$1.5M
Role of the transcription factor ARID3a in lupusR21AI090343 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI WEBB, CAROL F · 2010 to 2011
$430k
Role of the Transcription Factor ARID3a in Innate Immune ResponsesR56AI118836 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WEBB, CAROL F · 2015 to 2015
$370k
NIAID NIH HHS R01 AI044215NIAID NIH HHS R01 AI118836NIAID NIH HHS R21 AI090343NIAID NIH HHS R56 AI118836NIAID NIH HHS U19 AI062629NIAMS NIH HHS P30 AR053483
6 · The paper itself

Abstract

We recently reported that the transcription factor ARID3a is expressed in a subset of human hematopoietic progenitor stem cells in both healthy individuals and in patients with systemic lupus erythematosus. Numbers of ARID3a(+) lupus hematopoietic stem progenitor cells were associated with increased production of autoreactive Abs when those cells were introduced into humanized mouse models. Although ARID3a/Bright knockout mice died in utero, they exhibited decreased numbers of hematopoietic stem cells and erythrocytes, indicating that ARID3a is functionally important for hematopoiesis in mice. To explore the requirement for ARID3a for normal human hematopoiesis, hematopoietic stem cell progenitors from human cord blood were subjected to both inhibition and overexpression of ARID3a in vitro. Inhibition of ARID3a resulted in decreased B lineage cell production accompanied by increases in cells with myeloid lineage markers. Overexpression of ARID3a inhibited both myeloid and erythroid differentiation. Additionally, inhibition of ARID3a in hematopoietic stem cells resulted in altered expression of transcription factors associated with hematopoietic lineage decisions. These results suggest that appropriate regulation of ARID3a is critical for normal development of both myeloid and B lineage pathways.

Indexed as

Cell DifferentiationCell LineageDNA-Binding ProteinsFetal BloodFlow CytometryGene Knockdown TechniquesHematopoiesisHematopoietic Stem CellsHumansIn Vitro TechniquesOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionTranscription FactorsTransduction, GeneticARID3A protein, humanDNA-Binding ProteinsTranscription Factors

Identifiers

PMID26685208
PMCPMC4858324
OpenAlexW2229462743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.